Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000886591 | SCV001030106 | benign | not provided | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000886591 | SCV001713396 | uncertain significance | not provided | 2021-12-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000886591 | SCV004156381 | likely benign | not provided | 2022-06-01 | criteria provided, single submitter | clinical testing | PLG: BP4 |
Santos- |
RCV000999695 | SCV000996504 | uncertain significance | Otitis media, susceptibility to | 2019-07-26 | no assertion criteria provided | research | |
Prevention |
RCV003908140 | SCV004719322 | likely benign | PLG-related disorder | 2020-08-04 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |